Page last updated: 2024-12-11

1,2-bis(2-pyridyl)ethylene

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

## 1,2-Bis(2-pyridyl)ethylene: A Versatile Ligand

**1,2-Bis(2-pyridyl)ethylene**, also known as **BPE**, is an organic compound with the formula **C12H10N2**. It is a **bidentate ligand**, meaning it can coordinate to metal ions through two donor atoms. In the case of BPE, these donor atoms are the two nitrogen atoms of the pyridine rings.

**Structure and Properties:**

* BPE has a **planar structure** with two pyridine rings connected by a double bond.
* It is a **white solid** with a melting point of 70-72 °C.
* BPE is **soluble** in common organic solvents like chloroform, dichloromethane, and ethanol.

**Importance in Research:**

BPE is a versatile ligand with numerous applications in research, particularly in **coordination chemistry**, **catalysis**, and **materials science**. Here are some key areas where it plays a significant role:

**1. Catalyst Design:**

* BPE forms **stable complexes with various transition metals**, such as palladium, platinum, nickel, and copper.
* These complexes are widely used as **catalysts in organic reactions**, including **cross-coupling reactions**, **hydrogenation**, and **C-H activation**.
* BPE's rigid structure and strong coordination ability make it an ideal ligand for promoting catalytic activity and selectivity.

**2. Supramolecular Chemistry:**

* BPE can self-assemble into **supramolecular structures** with various metal ions and organic molecules.
* These structures exhibit interesting properties like **luminescence**, **conductivity**, and **non-linear optics**, making them promising candidates for applications in materials science.

**3. Metal-Organic Frameworks (MOFs):**

* BPE can act as a linker in the synthesis of **MOFs**, which are porous materials with high surface area and potential for various applications like gas storage, separation, and catalysis.
* BPE's rigid structure and multiple coordination sites make it a suitable building block for creating diverse and functional MOFs.

**4. Sensor Development:**

* BPE can be incorporated into **luminescent sensors** for detecting various analytes, including metal ions, organic molecules, and biological species.
* Its ability to bind to metal ions and its sensitivity to environmental changes make it a valuable component in sensor design.

**5. Pharmaceutical Research:**

* Some studies suggest BPE derivatives could possess **pharmacological activity**, such as anti-cancer and antimicrobial properties.
* Further research is needed to explore the potential of BPE in medicinal chemistry.

**Overall, 1,2-bis(2-pyridyl)ethylene is a versatile ligand with a wide range of applications in chemistry and materials science. Its unique properties make it a valuable tool for developing new catalysts, functional materials, and sensors with diverse applications.**

1,2-bis(2-pyridyl)ethylene: a drug metabolizing enzyme inducer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5374802
CHEMBL ID67376
SCHEMBL ID229328
MeSH IDM0523388

Synonyms (44)

Synonym
2-(2-pyridyl-2-vinyl)pyridine, trans-
13341-40-7
einecs 215-866-7
nsc 9489
nsc-9489
1437-15-6
nsc9489
mls000737910 ,
2-(2-pyridyl-2-vinyl)pyridine, trans
pyridine,2,2'-(1,2-ethenediyl)bis-(e)-
1,2-bis(2-pyridyl)ethylene
pyridine, 2,2'-(1,2-ethenediyl)bis-
1,2-bis(2-pyridyl)ethylene, 97%
smr000528086
B1131 ,
1,2-di(2-pyridyl)ethylene
CHEMBL67376 ,
2,2'-ethene-1,2-diyldipyridine
bdbm50279890
2-[(e)-2-pyridin-2-ylvinyl]pyridine
2-[(e)-2-pyridin-2-ylethenyl]pyridine
NCGC00246902-01
HMS2886B23
AE-641/02354001
AKOS015913730
pyridine, (1,2-ethenediyl)bis-
SCHEMBL229328
2,2'-vinylenedipyridine
pyridine, 2,2'-vinylenedi-
HKEOCEQLCZEBMK-BQYQJAHWSA-N
2-(2-(2-pyridinyl)ethenyl)pyridine
mfcd00006356
AS-62215
2-[2-(pyridin-2-yl)ethenyl]pyridine
2,2'-trans-vinylenedipyridine
J-007862
CS-0204870
1,2-di(pyridin-2-yl)ethene
Q63408675
(e)-1,2-bis(2-pyridinyl)ethene
(e)-1,2-di(pyridin-2-yl)ethene
BAA43715
2,2'-(1e)-1,2-ethenediylbis[pyridine]
DTXSID60871839
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (14)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, JmjC domain-containing histone demethylation protein 3AHomo sapiens (human)Potency28.18380.631035.7641100.0000AID504339
LuciferasePhotinus pyralis (common eastern firefly)Potency21.33130.007215.758889.3584AID588342
ATAD5 protein, partialHomo sapiens (human)Potency18.34890.004110.890331.5287AID504467
regulator of G-protein signaling 4Homo sapiens (human)Potency79.43280.531815.435837.6858AID504845
IDH1Homo sapiens (human)Potency10.32250.005210.865235.4813AID686970
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency1.12200.035520.977089.1251AID504332
serine-protein kinase ATM isoform aHomo sapiens (human)Potency0.31620.707925.111941.2351AID485349
NPC intracellular cholesterol transporter 1 precursorHomo sapiens (human)Potency2.81840.01262.451825.0177AID485313
vitamin D3 receptor isoform VDRAHomo sapiens (human)Potency79.43280.354828.065989.1251AID504847
ras-related protein Rab-9AHomo sapiens (human)Potency2.51190.00022.621531.4954AID485297
serine/threonine-protein kinase PLK1Homo sapiens (human)Potency26.67950.168316.404067.0158AID720504
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency89.12510.050127.073689.1251AID588590
gemininHomo sapiens (human)Potency23.10930.004611.374133.4983AID624297
muscleblind-like protein 1 isoform 1Homo sapiens (human)Potency14.12540.00419.962528.1838AID2675
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (13)

Assay IDTitleYearJournalArticle
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (30.00)29.6817
2010's6 (60.00)24.3611
2020's1 (10.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.97 (24.57)
Research Supply Index2.40 (2.92)
Research Growth Index4.37 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]